88777356 - MICRONOID

Information

• Trademark
• 88777356

• Source

• Serial Number

  88777356

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 29, 2020
  5 years ago

• Transaction Date

  April 07, 2024
  a year ago

• Status Date

  August 28, 2023
  a year ago

• Published for Opposition Date

  June 02, 2020
  4 years ago

• Location Date

  December 28, 2021
  3 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  RIRIE, VERNA BETH

• Attorney Docket Number

  CLTY-

  Attorney Name

  Camille M. Miller

  Law Office Assigned Location Code

  L40

• Owners

  • Celularity, Inc.

Case File Statements

• GS0051: Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
• GS0011: Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
• GS0421: Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

Case File Event Statements

• 8/28/2023 - a year ago

  36 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 8/28/2023 - a year ago

  35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 12/30/2022 - 2 years ago

  34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/29/2022 - 2 years ago

  33 - SOU EXTENSION 5 GRANTED Type: EX5G

• 12/27/2022 - 2 years ago

  32 - SOU EXTENSION 5 FILED Type: EXT5

• 12/27/2022 - 2 years ago

  31 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 6/29/2022 - 2 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/27/2022 - 2 years ago

  29 - SOU EXTENSION 4 GRANTED Type: EX4G

• 6/27/2022 - 2 years ago

  28 - SOU EXTENSION 4 FILED Type: EXT4

• 6/27/2022 - 2 years ago

  27 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 1/1/2022 - 3 years ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/30/2021 - 3 years ago

  25 - SOU EXTENSION 3 GRANTED Type: EX3G

• 12/30/2021 - 3 years ago

  24 - SOU EXTENSION 3 FILED Type: EXT3

• 12/30/2021 - 3 years ago

  23 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/28/2021 - 3 years ago

  22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 12/8/2021 - 3 years ago

  21 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 11/16/2021 - 3 years ago

  20 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 6/29/2021 - 3 years ago

  19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/25/2021 - 3 years ago

  18 - SOU EXTENSION 2 GRANTED Type: EX2G

• 6/25/2021 - 3 years ago

  17 - SOU EXTENSION 2 FILED Type: EXT2

• 6/25/2021 - 3 years ago

  16 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/31/2020 - 4 years ago

  15 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 12/29/2020 - 4 years ago

  14 - SOU EXTENSION 1 GRANTED Type: EX1G

• 12/29/2020 - 4 years ago

  13 - SOU EXTENSION 1 FILED Type: EXT1

• 12/29/2020 - 4 years ago

  12 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/8/2020 - 4 years ago

  11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/8/2020 - 4 years ago

  10 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/8/2020 - 4 years ago

  9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 7/28/2020 - 4 years ago

  8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 6/2/2020 - 4 years ago

  7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/2/2020 - 4 years ago

  6 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/13/2020 - 4 years ago

  5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/27/2020 - 4 years ago

  4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/17/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 2/4/2020 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/1/2020 - 5 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP